Lyka Labs Limited (LYKALABS.BO)
INR 110.15
(-0.68%)
INR 110.15
(-0.68%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.82 INR | 82.79% |
| 2022 | -4.59 INR | -133.77% |
| 2021 | 13.59 INR | 437.22% |
| 2020 | -4.03 INR | 81.04% |
| 2019 | -21.25 INR | -978.68% |
| 2018 | -1.97 INR | 70.55% |
| 2017 | -6.69 INR | -166.53% |
| 2016 | -2.51 INR | -248.52% |
| 2015 | 1.69 INR | 173.8% |
| 2014 | -2.29 INR | 24.92% |
| 2013 | -3.05 INR | -824.24% |
| 2012 | -0.33 INR | 0.0% |
| 2011 | - INR | -100.0% |
| 2010 | 1.12 INR | 139.16% |
| 2009 | -2.86 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.40 INR | 110.44% |
| 2023 Q4 | -3.83 INR | -809.26% |
| 2023 Q3 | 0.54 INR | 460.0% |
| 2023 Q2 | -0.15 INR | 73.68% |
| 2023 Q1 | -0.57 INR | 41.84% |
| 2023 FY | - INR | 82.79% |
| 2022 FY | - INR | -133.77% |
| 2022 Q4 | -0.98 INR | 73.0% |
| 2022 Q3 | -3.63 INR | -2492.86% |
| 2022 Q2 | -0.14 INR | -166.67% |
| 2022 Q1 | 0.21 INR | 103.99% |
| 2021 FY | - INR | 437.22% |
| 2021 Q2 | 9.91 INR | 45.52% |
| 2021 Q4 | -5.26 INR | -348.11% |
| 2021 Q1 | 6.81 INR | 1602.5% |
| 2021 Q3 | 2.12 INR | -78.61% |
| 2020 FY | - INR | 81.04% |
| 2020 Q1 | -1.64 INR | 72.53% |
| 2020 Q2 | -2.01 INR | -22.56% |
| 2020 Q3 | -0.80 INR | 60.2% |
| 2020 Q4 | 0.40 INR | 150.0% |
| 2019 Q2 | -1.14 INR | -0.88% |
| 2019 Q4 | -5.97 INR | 58.83% |
| 2019 Q3 | -14.50 INR | -1171.93% |
| 2019 FY | - INR | -978.68% |
| 2019 Q1 | -1.13 INR | -128.11% |
| 2018 Q1 | -1.79 INR | 0.0% |
| 2018 FY | - INR | 70.55% |
| 2018 Q4 | 4.02 INR | 475.7% |
| 2018 Q3 | -1.07 INR | 53.48% |
| 2018 Q2 | -2.30 INR | -28.49% |
| 2017 FY | - INR | -166.53% |
| 2016 Q1 | -1.89 INR | 60.21% |
| 2016 Q2 | 0.21 INR | 111.11% |
| 2016 Q3 | -1.32 INR | -728.57% |
| 2016 Q4 | 0.82 INR | 162.12% |
| 2016 FY | - INR | -248.52% |
| 2015 Q3 | 0.23 INR | -96.33% |
| 2015 Q2 | 6.26 INR | 712.99% |
| 2015 FY | - INR | 173.8% |
| 2015 Q1 | 0.77 INR | 153.1% |
| 2015 Q4 | -4.75 INR | -2165.22% |
| 2014 Q3 | -2.74 INR | -193.52% |
| 2014 Q2 | 2.93 INR | 168.14% |
| 2014 Q1 | -4.30 INR | 0.0% |
| 2014 FY | - INR | 24.92% |
| 2014 Q4 | -1.45 INR | 47.08% |
| 2013 Q1 | -1.14 INR | 0.0% |
| 2013 Q3 | -4.42 INR | -215.71% |
| 2013 FY | - INR | -824.24% |
| 2013 Q2 | -1.40 INR | -22.81% |
| 2012 Q4 | - INR | -100.0% |
| 2012 Q3 | 2.49 INR | 1210.53% |
| 2012 Q2 | 0.19 INR | -56.82% |
| 2012 FY | - INR | 0.0% |
| 2012 Q1 | 0.44 INR | 0.0% |
| 2011 Q3 | -1.07 INR | 0.0% |
| 2011 FY | - INR | -100.0% |
| 2010 FY | - INR | 139.16% |
| 2009 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 0.09 INR | 1035.006% |
| Biocon Limited | 8.55 INR | 109.591% |
| Blue Jet Healthcare Limited | 9.44 INR | 108.686% |
| Concord Biotech Limited | 29.45 INR | 102.784% |
| Dishman Carbogen Amcis Limited | -9.79 INR | 91.624% |
| FERMENTA BIOTECH LIMITED | -7.99 INR | 89.737% |
| GENOMIC VALLEY BIOTECH LIMITED | 0.05 INR | 1740.0% |
| Panacea Biotec Limited | -0.19 INR | -331.579% |
| SAMSRITA LABS LIMITED | -0.18 INR | -355.556% |
| Servoteach Industries Limited | -0.00 INR | -819900.0% |
| SMS Lifesciences India Limited | 30.08 INR | 102.726% |
| Supriya Lifescience Limited | 14.80 INR | 105.541% |
| Syngene International Limited | 12.71 INR | 106.452% |
| TAKE Solutions Limited | -8.18 INR | 89.976% |
| Titan Biotech Limited | 30.07 INR | 102.727% |
| Transgene Biotek Limited | -0.09 INR | -811.111% |
| Vanta Bioscience Limited | -3.67 INR | 77.657% |